Premium
Review of triazine antiprotozoal drugs used in veterinary medicine
Author(s) -
Stock M. L.,
Elazab S. T.,
Hsu W. H.
Publication year - 2018
Publication title -
journal of veterinary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.527
H-Index - 60
eISSN - 1365-2885
pISSN - 0140-7783
DOI - 10.1111/jvp.12450
Subject(s) - antiprotozoal , coccidiosis , toxoplasmosis , metronidazole , veterinary medicine , medicine , toxoplasma gondii , coccidiostats , pharmacology , traditional medicine , biology , virology , microbiology and biotechnology , immunology , antibiotics , biochemistry , antibody , in vitro
Triazines are relatively new antiprotozoal drugs that have successfully controlled coccidiosis and equine protozoal myeloencephalitis. These drugs have favorably treated other protozoal diseases such as neosporosis and toxoplasmosis. In this article, we discuss the pharmacological characteristics of five triazines, toltrazuril, ponazuril, clazuril, diclazuril, and nitromezuril which are used in veterinary medicine to control protozoal diseases which include coccidiosis, equine protozoal myeloencephalitis, neosporosis, and toxoplasmosis.